Vaxform, LLC, founded in 2010, is a contract development service provider specializing in the production of bacterial and virus vaccines, toxoids, and analogous products. The company's core mission is to advance public health through innovative vaccine solutions, with a vision of making high-quality vaccines accessible globally. Vaxform focuses on developing and manufacturing vaccines for various infectious diseases, catering primarily to the pharmaceutical and biotechnology markets.
Notable affiliated individuals and investors include experts in vaccine development and public health. Key achievements of Vaxform include the successful presentation of their QYNDR-RBD Phase I Trial at the World Vaccine Congress in Washington, DC. The company has made a significant impact by contributing to the development of critical vaccines, thereby enhancing global health security and preparedness against infectious diseases.
